BSE filing, NSE: AYMSYNTEX. Summary written from the filing by ALFA Finder's alert engine.
AYM Syntex Ltd: key numbers
- Share price
- ₹268.85
- Market cap
- ₹1,581 Cr
- Revenue (annual)
- ₹1,365 Cr
- Net profit (annual)
- ₹6.55 Cr
- P/E (TTM)
- 46.3×Sector 47.4×
- Promoter holding
- 65.67%-0.06% QoQ
- FII holding
- 3.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AYM Syntex Ltd
All →AYM Syntex Management Change
AYM Syntex appointed Kapil Mandawewala as Head – Textile Business Operations (Surat), effective November 16, 2026. He will lead and oversee the company's Surat textile operations.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM
AYM Syntex Q2 FY27 Results: Turns Profitable, Net Profit ₹15 Cr
AYM Syntex Ltd reported revenue from operations of ₹451.4 Cr (+29.3% YoY) and net profit of ₹15 Cr for Q2 FY27.
- Key figure
- Net profit ₹15 Cr
AYM Syntex Board Meeting Date
AYM Syntex Ltd will hold a board meeting on October 29, 2026, to approve the standalone and consolidated financial results for the quarter ended September 30, 2026.
AYM Syntex Other Announcement
AYM Syntex Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
AYM Syntex Legal & Regulatory
AYM Syntex received a GST show cause notice for F.Y. 2022-23 totaling ₹2.32 Crore, including tax, interest, and penalty. The company is evaluating the notice.
- Value
- ₹2.32 Cr
- From
- Department of Goods and Services Tax, Government of Maharashtra
Other acquisition announcements
All →Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.
Advent Hotels International Acquisition Worth ₹5.38 Cr
Advent Hotels acquired 50% control of Advent Convention and Hotels International Pvt Ltd for Rs.5.38 Crore cash. The target will develop a Mumbai commercial project.
- Value
- ₹5.38 Cr
- Execution
- Indicative completion date stated as 17-11-2026
Phoenix Mills Acquisition Worth ₹373.9 Cr
Phoenix Mills' stake in subsidiary ISMDPL rose to 71.23% after ISMDPL bought back CPP Investments' shares. Consideration was Rs.373.88 Crore, paid on 18 November 2026.
- Value
- ₹373.9 Cr
ACCEL Acquisition Worth ₹3.01 Cr
Accel will buy 2,98,399 Secureinteli shares at ₹101 each, lifting its stake to 84.10%. Secureinteli becomes a subsidiary, a deal worth about ₹3.01 Crore.
- Value
- ₹3.01 Cr
Prestige Estates Projects Acquisition Worth ₹2.69 Cr
Prestige's subsidiary acquired 50% of Advent Convention for ₹2.69 Crore. The target holds 21,978 sq. m land in Mumbai for a ₹4,500 Crore commercial project.
- Value
- ₹2.69 Cr
- leasable area
- 1500000 sq. ft.
Insecticides (India) Acquisition Worth ₹3.54 Cr
Insecticides (India) invested Rs. 3.54 Crore for a 26% stake in FP Alpha Private Limited. The acquisition targets wind and solar captive power capacity in Gujarat.
- Value
- ₹3.54 Cr